annual accounts payable:
$2.14M-$96.00K(-4.29%)Summary
- As of today (September 19, 2025), VRDN annual accounts payable is $2.14 million, with the most recent change of -$96.00 thousand (-4.29%) on December 31, 2024.
- During the last 3 years, VRDN annual accounts payable has fallen by -$186.00 thousand (-7.99%).
- VRDN annual accounts payable is now -84.94% below its all-time high of $14.23 million, reached on December 31, 2022.
Performance
VRDN Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$8.52M+$4.63M(+119.20%)Summary
- As of today (September 19, 2025), VRDN quarterly accounts payable is $8.52 million, with the most recent change of +$4.63 million (+119.20%) on June 30, 2025.
- Over the past year, VRDN quarterly accounts payable has increased by +$5.38 million (+171.27%).
- VRDN quarterly accounts payable is now -40.16% below its all-time high of $14.23 million, reached on December 31, 2022.
Performance
VRDN quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VRDN Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -4.3% | +171.3% |
3 y3 years | -8.0% | +109.8% |
5 y5 years | +95.5% | +2878.3% |
VRDN Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -84.9% | at low | -40.2% | +297.5% |
5 y | 5-year | -84.9% | +219.8% | -40.2% | +3571.6% |
alltime | all time | -84.9% | +7926.2% | -40.2% | >+9999.0% |
VRDN Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $8.52M(+119.2%) |
Mar 2025 | - | $3.89M(+81.3%) |
Dec 2024 | $2.14M(-4.3%) | $2.14M(-66.2%) |
Sep 2024 | - | $6.34M(+101.8%) |
Jun 2024 | - | $3.14M(+17.3%) |
Mar 2024 | - | $2.68M(+19.5%) |
Dec 2023 | $2.24M(-84.3%) | $2.24M(-40.1%) |
Sep 2023 | - | $3.73M(-9.6%) |
Jun 2023 | - | $4.13M(-47.5%) |
Mar 2023 | - | $7.87M(-44.7%) |
Dec 2022 | $14.23M(+511.2%) | $14.23M(+250.5%) |
Jun 2022 | - | $4.06M(+60.0%) |
Mar 2022 | - | $2.54M(+9.0%) |
Dec 2021 | $2.33M(+247.6%) | $2.33M(-37.6%) |
Sep 2021 | - | $3.73M(+56.0%) |
Jun 2021 | - | $2.39M(-29.3%) |
Mar 2021 | - | $3.38M(+405.1%) |
Dec 2020 | $670.00K(-38.9%) | $670.00K(+188.8%) |
Sep 2020 | - | $232.00K(-18.9%) |
Jun 2020 | - | $286.00K(-82.4%) |
Mar 2020 | - | $1.63M(+48.6%) |
Dec 2019 | $1.10M | $1.10M(-29.6%) |
Sep 2019 | - | $1.56M(+26.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $1.23M(+138.3%) |
Mar 2019 | - | $517.00K(-9.5%) |
Dec 2018 | $571.00K(-37.0%) | $571.00K(-52.7%) |
Sep 2018 | - | $1.21M(+161.6%) |
Jun 2018 | - | $461.00K(-39.3%) |
Mar 2018 | - | $760.00K(-16.1%) |
Dec 2017 | $906.00K(+469.8%) | $906.00K(+121.5%) |
Sep 2017 | - | $409.00K(-35.3%) |
Jun 2017 | - | $632.00K(-43.8%) |
Mar 2017 | - | $1.13M(+11.7%) |
Dec 2016 | $159.00K(-34.3%) | $1.01M(+1874.5%) |
Sep 2016 | - | $51.00K(-45.7%) |
Jun 2016 | - | $94.00K(-7.8%) |
Mar 2016 | - | $102.00K(-57.9%) |
Dec 2015 | $242.00K(-5.1%) | $242.00K(+24.1%) |
Sep 2015 | - | $195.00K(-41.3%) |
Jun 2015 | - | $332.00K(-13.5%) |
Mar 2015 | - | $384.00K(+50.6%) |
Dec 2014 | $255.00K(+155.0%) | $255.00K(+6.9%) |
Sep 2014 | - | $238.50K(+42.2%) |
Jun 2014 | - | $167.70K(>+9900.0%) |
Dec 2013 | $100.00K(+274.5%) | $0.00(-100.0%) |
Dec 2012 | $26.70K | - |
Dec 2012 | - | $26.70K |
FAQ
- What is Viridian Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Viridian Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of VRDN is $2.14M
What is the all time high annual accounts payable for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual accounts payable is $14.23M
What is Viridian Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, VRDN annual accounts payable has changed by -$96.00K (-4.29%)
What is Viridian Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of VRDN is $8.52M
What is the all time high quarterly accounts payable for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly accounts payable is $14.23M
What is Viridian Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, VRDN quarterly accounts payable has changed by +$5.38M (+171.27%)